Developing a Patient Safety Culture in Primary Dental Care.

Prim Dent J

Academic Clinical Fellow and Specialist Registrar in Oral Surgery, Institute of Dentistry, Queen Mary University of London & The Royal London Dental Hospital, Barts Health NHS Trust, London.

Published: March 2021

Patient safety should be at the heart of any healthcare service. Systems, teams, individuals and environments must work in tandem to strive for safety and quality. Research into patient safety in dentistry is still in the early stages. The vast majority of the research in this area has originated from the secondary care and academic fields. Approximately 95% of dental care is provided in the primary care sector. In this paper, we provide an overview of the evidence base for patient safety in dentistry and discuss the following aspects of patient safety: human factors; best practice; the second victim concept; potential for over-regulation and creating a patient safety culture. Through discussion of these concepts, we hope to provide the reader with the necessary tools to develop a patient safety culture in their practice.

Download full-text PDF

Source
http://dx.doi.org/10.1177/2050168420980990DOI Listing

Publication Analysis

Top Keywords

patient safety
28
safety culture
12
safety
8
dental care
8
safety dentistry
8
patient
6
developing patient
4
culture primary
4
primary dental
4
care
4

Similar Publications

"Thoracic anesthesia in patients with airborne disease".

Best Pract Res Clin Anaesthesiol

March 2024

Department of Surgery, Universitat de València, 46010 València, Spain; Ivano-Frankivsk National Medical University, 76018 Ivano-Frankivsk, Ukraine.

Health care workers are at risk of infection from aerosolization of respiratory secretions, droplet and contact spread. This has gained great importance after the COVID19 pandemic. Intra-operative aerosol-generating procedures are arguably unavoidable in the routine provision of thoracic anesthesia.

View Article and Find Full Text PDF

Preeclampsia and eclampsia: Enhanced detection and treatment for morbidity reduction.

Best Pract Res Clin Anaesthesiol

September 2024

Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, L1, Boston, MA, 02115, USA. Electronic address:

Preeclampsia is a life-threatening complication that develops in 2-8% of pregnancies. It is characterized by elevated blood pressure after 20 weeks of gestation and may progress to multiorgan dysfunction, leading to severe maternal and fetal morbidity and mortality. The only definitive treatment is delivery, and efforts are focused on early risk prediction, surveillance, and severity mitigation.

View Article and Find Full Text PDF

Initiation and maintenance of neuraxial labour analgesia: A narrative review.

Best Pract Res Clin Anaesthesiol

September 2024

Department of Anaesthesiology, GZA Hospitals, Antwerp, Belgium.

Labour analgesia is a crucial aspect of obstetric anaesthesia, aiming to alleviate pain during childbirth while ensuring maternal and foetal safety. Over the past decade, advancements in labour analgesia techniques have evolved, impacting initiation, maintenance, and outcomes. We emphasize the longstanding importance of epidural analgesia while recognizing the growing significance of combined spinal-epidural and dural puncture epidural techniques for labour initiation.

View Article and Find Full Text PDF

In the EU, conditional marketing authorization is a pragmatic tool for early approval of a medicine that fulfills an unmet medical need. In the pharmaceutical legislation, an unmet medical need means that a condition lacks a satisfactory method for diagnosis, prevention, or treatment. If such satisfactory methods exist, the new medicinal product must hold a major therapeutic advantage for those affected, meaning that it must demonstrate an improvement in efficacy or safety over existing methods or, in exceptional cases, a major improvement in patient care.

View Article and Find Full Text PDF

Exploration of the feasibility of clinical application of phage treatment for multidrug-resistant -induced pulmonary infection.

Emerg Microbes Infect

January 2025

Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province 518112, China.

() commonly induces refractory infection due to its multidrug-resistant nature. To date, there have been no reports on the application of phage treatment for infection. This study was conducted to explore the feasibility of phage application in treating refractory infection by collaborating with a 59-year-old male patient with a pulmonary infection of multidrug-resistant Our experiments included three domains: ) selection of the appropriate phage, ) verification of the efficacy and safety of the selected phage, ) confirmation of phage-bacteria interactions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!